These days, an S&P 500 fund is less a diversified investment than a bet on whether AI will pay off for a handful of the world’s biggest companies.

According to reporting from Bloomberg at the J.P. Morgan Healthcare Conference that ended today in San Francisco, ...

The Armenian American Medical Association of Boston (AAMA) and the Fund for Armenian Relief (FAR) have banded together to ...

In addition to Jefferies, Moderna also received a Hold from Morgan Stanley’s Terence Flynn in a report issued today. However, yesterday, Piper Sandler reiterated a Buy rating on Moderna (NASDAQ: MRNA) ...

Argus Research analyst Jasper Hellweg reiterated a Hold rating on Moderna yesterday. The company’s shares closed yesterday at $39.60. According to TipRanks, Hellweg is a 4-star analyst with an average ...

SAN FRANCISCO — Despite all the hopeful chatter about the life sciences industry making a rebound after a multiyear ...

AbbVie and Novartis strike billion-dollar pacts while attendees at the J.P. Morgan Healthcare Conference await that one big M ...

Venture investors are adopting a more aggressive mindset heading into 2026, while Merck, Moderna and Summit are all ...

The Department of Health and Human Services' decision to cut off funding to the group was likely retaliatory in nature, a federal judge ruled. The grants will be restored while the academy's lawsuit ...

Former Federal Reserve chiefs, Republican senators and — perhaps most important, many bond investors — raised concerns about ...

Moderna Inc.’s chairman says the Trump administration’s vaccine policy changes are part of a broader attack on science that ...

AI supercharges discovery; Nye and Afeyan warn U.S. anti-science cuts threaten health, competitiveness, future today.